New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma.

Sci Rep · 2019 · PMC6901480 · PMID 31819089

Europe PMC DOI

hedged sentence

0.1258

closest p · 2.5× alpha

0.1258

boldest claim

The sentences

did not reach statistical significancep = 0.1258not close (p > 0.1)

Patients with more advanced TNM stages (TNM II-IV) (3.73 CTCs/mL, n = 26) had higher number of CTCs compared to early stage HCC patients (TNM 0-I) (2.76 CTCs/mL, n = 16), however this did not reach statistical significance (p = 0.1258) (Fig. 2B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.